RCKT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Rocket Pharmaceuticals Inc (RCKT).


$1.15B Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

RCKT Market Cap. (MRY)


RCKT Shares Outstanding (MRY)


RCKT Assets (MRY)


Total Assets

$527.70M

Total Liabilities

$64.47M

Total Investments

$208.70M

RCKT Income (MRY)


Revenue

$0

Net Income

-$258.75M

Operating Expense

$273.20M

RCKT Cash Flow (MRY)


CF Operations

-$209.72M

CF Investing

$131.71M

CF Financing

$185.74M

RCKT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RCKT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$527,700,000 (-6.82%)

$566,341,000 (2.63%)

$551,807,000 (11.02%)

$497,020,000 (-15.88%)

Assets Current

$378,183,000 (-0.01%)

$378,222,000 (3.89%)

$364,060,000 (-7.14%)

$392,059,000 (-19.55%)

Assets Non-Current

$149,517,000 (-20.52%)

$188,119,000 (0.20%)

$187,747,000 (78.87%)

$104,961,000 (1.43%)

Goodwill & Intangible Assets

$64,304,000 (0.00%)

$64,304,000 (-0.88%)

$64,878,000 (110.54%)

$30,815,000 (0.00%)

Shareholders Equity

$463,234,000 (-5.96%)

$492,574,000 (0.59%)

$489,686,000 (7.69%)

$454,724,000 (-9.69%)

Property Plant & Equipment Net

$83,322,000 (-4.87%)

$87,590,000 (12.81%)

$77,645,000 (7.32%)

$72,348,000 (2.42%)

Cash & Equivalents

$165,526,000 (186.33%)

$57,809,000 (-59.42%)

$142,465,000 (-39.25%)

$234,492,000 (-21.61%)

Accumulated Other Comprehensive Income

$66,000 (-79.31%)

$319,000 (189.36%)

-$357,000 (-121.74%)

-$161,000 (-283.33%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$208,701,000 (-40.64%)

$351,591,000 (35.67%)

$259,153,000 (66.07%)

$156,046,000 (-15.93%)

Investments Current

$208,701,000 (-34.22%)

$317,271,000 (46.97%)

$215,877,000 (38.34%)

$156,046,000 (-15.93%)

Investments Non-Current

$0 (0%)

$34,320,000 (-20.70%)

$43,276,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$37,827,000 (-17.39%)

$45,789,000 (24.90%)

$36,660,000 (86.90%)

$19,615,000 (-22.99%)

Accumulated Retained Earnings (Deficit)

-$1,218,116,000 (-26.97%)

-$959,370,000 (-34.41%)

-$713,775,000 (-45.10%)

-$491,912,000 (-52.37%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$25,498,000 (1.82%)

$25,042,000 (9.52%)

$22,866,000 (1.17%)

$22,601,000 (-63.37%)

Debt Current

$2,857,000 (5.19%)

$2,716,000 (8.25%)

$2,509,000 (-1.68%)

$2,552,000 (-64.28%)

Debt Non-Current

$22,641,000 (1.41%)

$22,326,000 (9.67%)

$20,357,000 (1.54%)

$20,049,000 (-63.25%)

Total Liabilities

$64,466,000 (-12.61%)

$73,767,000 (18.75%)

$62,121,000 (46.87%)

$42,296,000 (-51.55%)

Liabilities Current

$40,684,000 (-16.12%)

$48,505,000 (23.84%)

$39,169,000 (76.70%)

$22,167,000 (-32.04%)

Liabilities Non-Current

$23,782,000 (-5.86%)

$25,262,000 (10.06%)

$22,952,000 (14.02%)

$20,129,000 (-63.19%)

RCKT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$101,961,000 (39.07%)

$73,317,000 (24.75%)

$58,773,000 (40.70%)

$41,772,000 (44.72%)

Research & Development Expense

$171,244,000 (-8.10%)

$186,342,000 (12.55%)

$165,570,000 (31.95%)

$125,476,000 (19.00%)

Operating Expenses

$273,205,000 (5.22%)

$259,659,000 (15.74%)

$224,343,000 (34.14%)

$167,248,000 (24.53%)

Interest Expense

$1,886,000 (0.59%)

$1,875,000 (0.70%)

$1,862,000 (-37.45%)

$2,977,000 (-57.27%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$258,746,000 (-5.35%)

-$245,595,000 (-10.70%)

-$221,863,000 (-31.23%)

-$169,069,000 (-21.02%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$258,746,000 (-5.35%)

-$245,595,000 (-10.70%)

-$221,863,000 (-31.23%)

-$169,069,000 (-21.02%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$258,746,000 (-5.35%)

-$245,595,000 (-10.70%)

-$221,863,000 (-31.23%)

-$169,069,000 (-21.02%)

Weighted Average Shares

$94,807,773 (12.85%)

$84,009,004 (23.27%)

$68,148,925 (7.77%)

$63,235,417 (14.18%)

Weighted Average Shares Diluted

$94,807,773 (12.85%)

$84,009,004 (23.27%)

$68,148,925 (7.77%)

$63,235,417 (14.18%)

Earning Before Interest & Taxes (EBIT)

-$256,860,000 (-5.39%)

-$243,720,000 (-10.78%)

-$220,001,000 (-32.46%)

-$166,092,000 (-25.13%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$273,205,000 (-5.22%)

-$259,659,000 (-15.74%)

-$224,343,000 (-34.14%)

-$167,248,000 (-24.53%)

RCKT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$131,706,000 (234.30%)

-$98,066,000 (-41.46%)

-$69,326,000 (-467.72%)

$18,853,000 (119.52%)

Net Cash Flow from Financing

$185,739,000 (-10.87%)

$208,401,000 (34.20%)

$155,288,000 (312.11%)

$37,681,000 (-86.68%)

Net Cash Flow from Operations

-$209,724,000 (-7.60%)

-$194,916,000 (-9.42%)

-$178,142,000 (-47.03%)

-$121,163,000 (-62.33%)

Net Cash Flow / Change in Cash & Cash Equivalents

$107,721,000 (227.36%)

-$84,581,000 (8.24%)

-$92,180,000 (-42.63%)

-$64,629,000 (-157.83%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$42,726,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$137,568,000 (268.60%)

-$81,594,000 (21.11%)

-$103,433,000 (-489.31%)

$26,568,000 (139.34%)

Capital Expenditure

-$5,862,000 (64.41%)

-$16,472,000 (-91.11%)

-$8,619,000 (-11.72%)

-$7,715,000 (73.45%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$185,739,000 (-10.87%)

$208,401,000 (34.20%)

$155,288,000 (312.11%)

$37,681,000 (-86.72%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$43,920,000 (11.46%)

$39,406,000 (27.08%)

$31,009,000 (6.06%)

$29,237,000 (57.47%)

Depreciation Amortization & Accretion

$9,375,000 (32.08%)

$7,098,000 (13.28%)

$6,266,000 (16.62%)

$5,373,000 (-14.03%)

RCKT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-63.90% (-23.36%)

-51.80% (3.00%)

-53.40% (-50.85%)

-35.40% (17.87%)

Return on Average Assets (ROAA)

-55.40% (-20.70%)

-45.90% (3.77%)

-47.70% (-50.95%)

-31.60% (6.51%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-82.10% (-21.09%)

-67.80% (21.80%)

-86.70% (-35.26%)

-64.10% (-14.46%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.6 (55.14%)

-10.26 (-70.98%)

-6 (26.58%)

-8.18 (62.43%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

2.47 (-54.90%)

5.49 (81.36%)

3.02 (-2.23%)

3.09 (-48.57%)

Debt to Equity Ratio (D/E)

0.14 (-7.33%)

0.15 (18.11%)

0.13 (36.56%)

0.09 (-46.24%)

Earnings Per Share (EPS)

-2.73 (6.51%)

-2.92 (10.43%)

-3.26 (-22.10%)

-2.67 (-5.95%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.27 (9.62%)

-2.52 (8.18%)

-2.74 (-34.45%)

-2.04 (-8.87%)

Book Value Per Share (BVPS)

4.89 (-16.66%)

5.86 (-18.41%)

7.19 (-0.07%)

7.19 (-20.91%)

Tangible Assets Book Value Per Share (TABVPS)

4.89 (-18.21%)

5.98 (-16.36%)

7.14 (-3.09%)

7.37 (-27.09%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (60.00%)

-10 (-66.67%)

-6 (14.29%)

-7 (69.57%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.46 (57.77%)

-10.56 (-73.04%)

-6.11 (16.97%)

-7.35 (69.14%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

9.3 (19.21%)

7.8 (-16.11%)

9.29 (-47.45%)

17.69 (18.38%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$215,586,000 (-1.99%)

-$211,388,000 (-13.19%)

-$186,761,000 (-44.91%)

-$128,878,000 (-24.28%)

Enterprise Value (EV)

$1,104,022,558 (-55.83%)

$2,499,674,083 (91.58%)

$1,304,758,158 (10.40%)

$1,181,829,980 (-60.78%)

Earnings Before Tax (EBT)

-$258,746,000 (-5.35%)

-$245,595,000 (-10.70%)

-$221,863,000 (-31.23%)

-$169,069,000 (-21.02%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$247,485,000 (-4.59%)

-$236,622,000 (-10.71%)

-$213,735,000 (-32.99%)

-$160,719,000 (-27.07%)

Invested Capital

$282,684,000 (-32.82%)

$420,765,000 (28.22%)

$328,161,000 (41.36%)

$232,147,000 (-19.94%)

Working Capital

$337,499,000 (2.36%)

$329,717,000 (1.49%)

$324,891,000 (-12.17%)

$369,892,000 (-18.66%)

Tangible Asset Value

$463,396,000 (-7.70%)

$502,037,000 (3.10%)

$486,929,000 (4.45%)

$466,205,000 (-16.75%)

Market Capitalization

$1,145,844,558 (-57.59%)

$2,702,062,083 (82.43%)

$1,481,144,158 (5.29%)

$1,406,781,980 (-53.56%)

Average Equity

$404,785,500 (-14.58%)

$473,876,500 (14.03%)

$415,578,750 (-12.96%)

$477,454,500 (47.14%)

Average Assets

$466,810,250 (-12.81%)

$535,410,250 (15.08%)

$465,268,500 (-12.99%)

$534,724,750 (29.46%)

Invested Capital Average

$312,772,000 (-13.00%)

$359,503,500 (41.74%)

$253,640,000 (-2.10%)

$259,068,000 (9.30%)

Shares

91,157,085 (1.11%)

90,158,895 (19.12%)

75,684,423 (17.44%)

64,442,601 (16.67%)